These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 2935084)
41. Pharmacoclinical data on high dose medroxyprogesterone acetate in advanced breast cancer. Namer M; Milano G; Khater R; Frenay M; Thyss A; Renée N Breast Cancer Res Treat; 1986; 8(2):161-3. PubMed ID: 2949788 [No Abstract] [Full Text] [Related]
42. A human tumour model. Forrest AP; Levack PA; Chetty U; Hawkins RA; Miller WR; Smyth JF; Anderson TJ Lancet; 1986 Oct; 2(8511):840-2. PubMed ID: 2876282 [TBL] [Abstract][Full Text] [Related]
43. New trends in the use of medroxyprogesterone acetate as a chemotherapeutic agent in gynecologic malignancies. Vanderstappen D; Bonte J Eur J Gynaecol Oncol; 1992; 13(2):113-23. PubMed ID: 1534051 [TBL] [Abstract][Full Text] [Related]
44. The clinical investigator and the evolution of the treatment of primary breast cancer. Carbone PP; Tormey DC Semin Oncol; 1986 Dec; 13(4):415-24. PubMed ID: 3541213 [No Abstract] [Full Text] [Related]
45. [Therapy of recurrent breast neoplasms]. Koike A; Kasumi F Nihon Geka Gakkai Zasshi; 1994 Sep; 95(9):562-3. PubMed ID: 7838101 [No Abstract] [Full Text] [Related]
46. Adjuvant and neoadjuvant treatment of breast cancer with chemotherapy and/or endocrine therapy. Bonadonna G; Valagussa P; Brambilla C; Moliterni A; Zambetti M; Ferrari L Semin Oncol; 1991 Dec; 18(6):515-24. PubMed ID: 1775970 [No Abstract] [Full Text] [Related]
47. Cyclic hormonal treatment in ovarian cancer. A phase-II trial. Jakobsen A; Bertelsen K; Sell A Eur J Cancer Clin Oncol; 1987 Jul; 23(7):915-6. PubMed ID: 2959486 [TBL] [Abstract][Full Text] [Related]
48. Adjuvant therapy for breast cancer: understanding the overview. International Breast Cancer Study Group. Gelber RD; Goldhirsch A; Coates AS J Clin Oncol; 1993 Mar; 11(3):580-5. PubMed ID: 8445434 [No Abstract] [Full Text] [Related]
49. Hormone conditioned cancer chemotherapy for recurrent breast cancer prolongs survival. Sugimachi K; Inokuchi K; Matsuura H; Ueo H; Kumashiro R Jpn J Surg; 1984 May; 14(3):217-21. PubMed ID: 6748393 [TBL] [Abstract][Full Text] [Related]
50. [Application and results of various therapeutic methods in recurrent breast cancer]. Okabe N Rinsho Hoshasen; 1975 Feb; 20(2):187-9. PubMed ID: 1169444 [No Abstract] [Full Text] [Related]
51. [Additional treatment with Esberitox N in patients with chemo-radiotherapy treatment of advanced breast cancer]. Bendel R; Bendel V; Renner K; Carstens V; Stolze K Onkologie; 1989 Jun; 12 Suppl 3():32-8. PubMed ID: 2481832 [TBL] [Abstract][Full Text] [Related]
52. Primary osteosarcoma of the breast--case report and review of the literature. Kaiser U; Barth P; Duda V; Pflüger KH; Havemann K Acta Oncol; 1994; 33(1):74-6. PubMed ID: 8142130 [No Abstract] [Full Text] [Related]
53. The many options in management of breast cancer. Tashima CK Geriatrics; 1976 Jun; 31(6):97-100. PubMed ID: 1278699 [No Abstract] [Full Text] [Related]
54. Panel reviews therapy for early breast cancer; explicit advice on adjuvant therapy lacking. Clin Pharm; 1990 Sep; 9(9):667-8. PubMed ID: 2225747 [No Abstract] [Full Text] [Related]
55. An overview of risk factors for recurrent breast cancer. Mannell A S Afr J Surg; 2017 Mar; 55(1):29-34. PubMed ID: 28876555 [TBL] [Abstract][Full Text] [Related]
56. Immunotherapy for breast cancer: is it feasible? Clarke E Immunotherapy; 2015; 7(11):1135-43. PubMed ID: 26567869 [No Abstract] [Full Text] [Related]
57. [Therapeutic strategy of localized and generalized breast cancer]. Paridaens R; Regnier R; Mattheiem WH; Heuson JC Rev Med Liege; 1984 Feb; 39(3):11-5. PubMed ID: 6718863 [No Abstract] [Full Text] [Related]
58. SEOM clinical guidelines in advanced and recurrent breast cancer (2018). Chacón López-Muñiz JI; de la Cruz Merino L; Gavilá Gregori J; Martínez Dueñas E; Oliveira M; Seguí Palmer MA; Álvarez López I; Antolin Novoa S; Bellet Ezquerra M; López-Tarruella Cobo S Clin Transl Oncol; 2019 Jan; 21(1):31-45. PubMed ID: 30617924 [TBL] [Abstract][Full Text] [Related]
59. Estrogen receptor variations in neoplastic tissue during the course of disease in patients with recurrent breast cancer. Toma S; Leclercq G; Legros N; Sylvester RJ; Heuson JC; Paridaens RJ Recent Results Cancer Res; 1984; 91():181-5. PubMed ID: 6729214 [No Abstract] [Full Text] [Related]
60. Unresolved questions in breast cancer therapy. Budd GT; Cheng SS; Grundfest S Cleve Clin J Med; 1991; 58(5):376-7. PubMed ID: 1934450 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]